There’s no doubt that the evolution of drug-resistant antibacterial is a worrying trend. Methicillin-resistant Staphylococcus aureus (MRSA) may have taken most of the headlines, but while we’ve been discussing how best to wash our hands in hospital wards, other, more insidious resistant bacteria have come to the fore.
Medical illustration of extended-spectrum β-lactamase – Image courtesy of the Centres for Disease Control and Prevention
In March, Sally Davies, the UK’s Chief Medical Officer described antimicrobial resistance as posing a ‘catastrophic threat’. And recently, Tom Frieden, Director of the US Centres of Disease Control and Prevention (CDC), warned ‘If we are not careful, we will soon be in a post-antibiotic era … and for some patients and for some microbes, we are already there.’
This month saw the publication of a two key reports: the UK five year antimicrobial resistance strategy 2013 to 2018 published by the Department of Health and Department for Environment, Food and Rural Affairs; and the CDC tome Antibiotic resistance threats in the United States, 2013. In a little over 140 pages between them they scan the landscape, identifying and, for the first time, classifying the threats posed by antibiotic resistant bacteria. (more…)